Oligonucleotides as radiopharmaceuticals

被引：0
作者：
Tavitian, B [1 ]
机构：
[1] INSERM, ERM 103, Serv Hosp Frederic Joliot, CEA Direct Sci Vivant Direct Rech Med, F-91401 Orsay, France
来源：
MOLECUALR IMAGING: AN ESSENTIAL TOOL IN PRECLINICAL RESEARCH, DIAGNOSTIC IMAGING, AND THERAPY | 2005年 / 49卷
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
引用
收藏
页码：1 / 34
页数：34
相关论文
共 118 条
[1]   Oligonucleotide therapeutics for hematologic disorders [J].
Agarwal, N ;
Gewirtz, AM .
BIOCHIMICA ET BIOPHYSICA ACTA-GENE STRUCTURE AND EXPRESSION, 1999, 1489 (01) :85-96
[2]   Antisense oligonucleotides: Towards clinical trials [J].
Agrawal, S .
TRENDS IN BIOTECHNOLOGY, 1996, 14 (10) :376-387
[3]  
Agrawal S., 1996, ANTISENSE THERAPEUTI
[4]   In vivo studies with antisense oligonucleotides [J].
Akhtar, S ;
Agrawal, S .
TRENDS IN PHARMACOLOGICAL SCIENCES, 1997, 18 (01) :12-18
[5]   Results of a pilot study involving the use of an antisense oligodeoxynucleotide directed against the insulin-like growth factor type I receptor in malignant astrocytomas [J].
Andrews, DW ;
Resnicoff, M ;
Flanders, AE ;
Kenyon, L ;
Curtis, M ;
Merli, G ;
Baserga, R ;
Iliakis, G ;
Aiken, RD .
JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (08) :2189-2200
[6]   2'-FLUORO-2'-DEOXYNUCLEOSIDE AND 2'-AMINO-2'-DEOXYNUCLEOSIDE 5'-TRIPHOSPHATES AS SUBSTRATES FOR T7 RNA-POLYMERASE [J].
AURUP, H ;
WILLIAMS, DM ;
ECKSTEIN, F .
BIOCHEMISTRY, 1992, 31 (40) :9636-9641
[7]   INTERACTION OF CATIONIC LIPOSOMES WITH CELLS OF ELECTRICALLY ACTIVE NEURONAL NETWORKS IN CULTURE [J].
AZZAZY, HME ;
KONG, KL ;
WU, MC ;
GROSS, GW .
BRAIN RESEARCH, 1995, 695 (02) :231-236
[8]   BINDING OF PHOSPHOROTHIOATE OLIGODEOXYNUCLEOTIDES TO BASIC FIBROBLAST GROWTH-FACTOR, RECOMBINANT SOLUBLE CD4, LAMININ AND FIBRONECTIN IS P-CHIRALITY INDEPENDENT [J].
BENIMETSKAYA, L ;
TONKINSON, JL ;
KOZIOLKIEWICZ, M ;
KARWOWSKI, B ;
GUGA, P ;
ZELTSER, R ;
STEC, W ;
STEIN, CA .
NUCLEIC ACIDS RESEARCH, 1995, 23 (21) :4239-4245
[9]   Specific oligobodies against ERK-2 that recognize both the native and the denatured state of the protein [J].
Bianchini, M ;
Radrizzani, M ;
Brocardo, MG ;
Reyes, GB ;
Solveyra, CG ;
Santa-Coloma, TA .
JOURNAL OF IMMUNOLOGICAL METHODS, 2001, 252 (1-2) :191-197
[10]   Phase I trial of an antisense oligonucleotide OL(1)p53 in hematologic malignancies [J].
Bishop, MR ;
Iversen, PL ;
Bayever, E ;
Sharp, JG ;
Greiner, TC ;
Copple, BL ;
Ruddon, R ;
Zon, G ;
Spinolo, J ;
Arneson, M ;
Armitage, JO ;
Kessinger, A .
JOURNAL OF CLINICAL ONCOLOGY, 1996, 14 (04) :1320-1326
12345678910